EPIC PHARMA LLC FDA Approval ANDA 077022

ANDA 077022

EPIC PHARMA LLC

FDA Drug Application

Application #077022

Documents

Letter2004-12-02

Application Sponsors

ANDA 077022EPIC PHARMA LLC

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL100MG0CILOSTAZOLCILOSTAZOL
002TABLET;ORAL50MG0CILOSTAZOLCILOSTAZOL

FDA Submissions

ORIG1AP2004-11-23
LABELING; LabelingSUPPL2AP2006-02-14
LABELING; LabelingSUPPL3AP2008-02-14
LABELING; LabelingSUPPL5AP2010-05-27
LABELING; LabelingSUPPL7AP2010-07-06
LABELING; LabelingSUPPL8AP2017-03-21STANDARD
LABELING; LabelingSUPPL9AP2020-11-18STANDARD

Submissions Property Types

SUPPL5Null8
SUPPL7Null7
SUPPL8Null7
SUPPL9Null7

CDER Filings

EPIC PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77022
            [companyName] => EPIC PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CILOSTAZOL","activeIngredients":"CILOSTAZOL","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CILOSTAZOL","submission":"CILOSTAZOL","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.